M6620 (VX-970) in Selected Solid Tumors

NCT03718091 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Solid Tumor
Leiomyosarcoma
Osteosarcoma

Interventions

DRUG: M6620

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]